Algeria vs Morocco: Share of pregnant women with HIV that receive antiretroviral therapy
Algeria
74.0%
in 2019
Morocco
72.0%
in 2024
Algeria rank
48th
Morocco rank
49th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Algeria
- Morocco
How they compare
Algeria currently reports 74.0% against 72.0% in Morocco, a difference of 2.0%.
The two have swapped places 3 times across 20 shared years of data; in 2000 it was Morocco ahead.
Algeria ranks 48th and Morocco ranks 49th of 84 countries.
Algeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Algeria | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 3.9% | 3.0% | Algeria |
| 2010s | 52.5% | 34.4% | 18.1% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Algeria or Morocco?
- Algeria, at 74.0% against 72.0% in Morocco as of 2019.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Algeria and Morocco?
- 2.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Morocco?
- 20 years are reported by both, from 2000 to 2019.
- How do Algeria and Morocco rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Algeria ranks 48th and Morocco ranks 49th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.